Skip to main content
SpringerLink
Log in

Vestibular migraine treatment and prevention

Behandlung und Prävention von vestibulärer Migräne

  • Leitthema
  • Published:
HNO Aims and scope Submit manuscript

Abstract

Vestibular migraine probably represents the second most common cause of vertigo after benign positional vertigo, by far exceeding Ménière disease. There are still relatively few published reports on vestibular migraine management, despite its enormous importance in daily practice. In 2003 the first clinical definition of vestibular migraine was proposed. Studies published before 2003 used variable terms for vestibular migraine. Some authors recommend treating vestibular migraine using multiple drugs; others have focused on using only one drug. Although at present it is not possible to quantify the effects of the treatments proposed, some recommendations can be made.

Zusammenfassung

Die vestibuläre Migräne ist wahrscheinlich die zweithäufigste Ursache für Schwindel nach dem gutartigen positionellen Schwindel, der die Menière-Krankheit bei Weitem übersteigt. Es gibt bisher nur wenige veröffentlichte Berichte über die Behandlung der vestibulären Migräne, trotz ihrer enormen Bedeutung für die tägliche Praxis. Im Jahr 2003 wurde die erste klinische Definition der vestibulären Migräne vorgeschlagen. Vor 2003 veröffentlichte Studien verwendeten variable Begriffe für vestibuläre Migräne. Einige Autoren empfehlen die Behandlung der vestibulären Migräne mit mehreren Medikamenten, andere haben sich auf die Verwendung nur eines Medikaments konzentriert. Derzeit ist es zwar nicht möglich, die Auswirkungen der vorgeschlagenen Behandlungen zu quantifizieren, aber es können einige Empfehlungen ausgesprochen werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lempert T, Neuhauser H (2009) Epidemiology of vertigo, migraine and vestibular vertigo. J Neurol 256:333–338

    Article  PubMed  Google Scholar 

  2. Furman JM, Marcus DA, Balaban CD (2003) Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 16:5–13

    Article  PubMed  Google Scholar 

  3. Ménière P (1861) Memoire sur des lesions de loreille interne donnant lieu a des symptomes de congestion cerebrale apoplectiforme. Gaz Med 16:597–601

    Google Scholar 

  4. Symonds CP (1926) Vertigo. J Postgrad Med 1:63–66

    Article  CAS  Google Scholar 

  5. Graham JR (1968) Migraine: clinical aspects. In: Vinken PJ, Bruin GW (eds) Handbook of clinical neurology, 1st edn. North-Holland, Amsterdam, pp 45–58

    Google Scholar 

  6. Kayan A, Hood JD (1984) Neuro-otological manifestations of migraine. Brain 107:1123–1142

    Article  PubMed  Google Scholar 

  7. Neuhauser HK, Radtke A, von Brevern M et al (2006) Migrainous vertigo: prevalence and impact on quality of life. Baillieres Clin Neurol 67(6):1028–1033

    CAS  Google Scholar 

  8. Cutrer FM, Baloh RW (1992) Migraine-associated dizziness. Headache 32:300–304

    Article  CAS  PubMed  Google Scholar 

  9. Vukovic V, Plavec D, Galinovic I, Lovrencic-Huzja A, Budisic M, Demarin V (2007) Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache 47:1427–1435

    Article  PubMed  Google Scholar 

  10. Neuhauser H, Lempert T (2004) Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalgia 24:83–91

    Article  CAS  Google Scholar 

  11. von Brevern M, Zeise D, Neuhauser H, Clarke AH, Lempert T (2005) Acute migrainous vertigo: clinical and oculographic findings. Brain 128:365–374

    Article  Google Scholar 

  12. Baloh RW (1997) Neurotology of migraine. Headache 37:615–621

    Article  CAS  PubMed  Google Scholar 

  13. Vincent M, Hadjikhani N (2007) The cerebellum and migraine. Headache 47:820–833

    Article  PubMed  PubMed Central  Google Scholar 

  14. Goadsby PJ (2009) The vascular theory of migraine—a great story wrecked by the facts. Brain 132:6–7

    Article  PubMed  Google Scholar 

  15. Russo A, Marcelli V, Esposito F et al (2014) Abnormal thalamic function in patients with vestibular migraine. Baillieres Clin Neurol 82(23):2120–2126

    Google Scholar 

  16. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009) Neurobiology of migraine. Neuroscience 161:327–341

    Article  CAS  PubMed  Google Scholar 

  17. Jen J, Kim GW, Baloh RW (2004) Clinical spectrum of episodic ataxia type 2. Baillieres Clin Neurol 62:17–22

    CAS  Google Scholar 

  18. Lee H, Jen JC, Wang H et al (2006) A genome-wide linkage scan of familial benign recurrent vertigo: linkage to 22q12 with evidence of heterogeneity. Hum Mol Genet 15(2):251–258

    Article  CAS  PubMed  Google Scholar 

  19. Lee H, Sininger L, Jen JC et al (2007) Association of progesterone receptor with migraine-associated vertigo. Neurogenetics 8(3):195–200

    Article  CAS  PubMed  Google Scholar 

  20. Furman JM, Marcus DA, Balaban CD (2013) Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol 12(7):706–715

    Article  CAS  PubMed  Google Scholar 

  21. Neuhauser H, Leopold HM, von Brevern M, Arnold G, Lempert T (2001) The interrelations of migraine, vertigo, and migrainous vertigo. Baillieres Clin Neurol 56:436–441

    CAS  Google Scholar 

  22. International Headache Soxiety (2018) The international classification of headache disorders, 3rd edition [beta version]. Cephalgia 38(1):1–211

    Article  Google Scholar 

  23. Olsson JE (1991) Neurotologic findings in basilar migraine. Laryngoscope 101(Suppl 52):1–41

    Article  CAS  PubMed  Google Scholar 

  24. Celebisoy N, Gokcay F, Sirin H et al (2008) Migrainous vertigo: clincal, oculographic and posturographic findings. Cephalgia 28(1):72–77

    Article  CAS  Google Scholar 

  25. Rang HP, Dale MM, Ritter JM, Moore PK (2003) Pharmacology. Elsevier, Bath

    Google Scholar 

  26. Tusa RJ (1999) Diagnosis and management of neuro-otological disorders due to migraine. In: Herdmann SJ (ed) Vestibular rehabilitation. FA Davis, Philadelphia, pp 298–315

    Google Scholar 

  27. Olesen J (1988) Calcium entry blockers in the treatment of vertigo. Ann N Y Acad Sci 522:690–697

    Article  CAS  PubMed  Google Scholar 

  28. Reploeg MD, Goebel JA (2002) Migraine-associated dizziness: Patient characteristics and management options. Otol Neurotol 23:364–371

    Article  PubMed  Google Scholar 

  29. Ramadan NM (2007) Current trends in migraine prophylaxis. Headache 47(Suppl 1):S52–S57

    Article  PubMed  Google Scholar 

  30. Furman JM, Balaban CD, Jacob RG, Marcus DA (2005) Migraine–anxiety related dizziness (MARD): a new disorder? J Neurol Neurosurg Psychiatry 76:1–8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Albera R, Ciuffolotti R, Di Cicco M, De Benedittis G, Grazioli I, Melzi G et al (2003) Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 123:588–593

    Article  CAS  PubMed  Google Scholar 

  32. Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R (1991) Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière’s disease. Acta Otolaryngol Suppl 490:1–10

    Article  CAS  PubMed  Google Scholar 

  33. Vahedi K, Taupin P, Djomby R, El-Amrani M, Lutz G, Filipetti V et al (2002) Efficacy and tolerability of acetazolamide in migraine prophylaxis: A randomised placebo-controlled trial. J Neurol 249:206–211

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St James & Capua Hospitals, George Borg Olivier St, SLM 1807, Sliema, Malta

    A. Lapira MD, MA, MSc, DLORCS, AuD, FAAA

  2. University of Malta, Msida, Malta

    A. Lapira MD, MA, MSc, DLORCS, AuD, FAAA

  3. Nova Southeastern University, Fort Lauderdale, FL, USA

    A. Lapira MD, MA, MSc, DLORCS, AuD, FAAA

Authors
  1. A. Lapira MD, MA, MSc, DLORCS, AuD, FAAA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Lapira MD, MA, MSc, DLORCS, AuD, FAAA.

Ethics declarations

Conflict of interest

A. Lapira declares that he has no competing interests.

For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lapira, A. Vestibular migraine treatment and prevention. HNO 67, 425–428 (2019). https://doi.org/10.1007/s00106-019-0661-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00106-019-0661-3

Keywords

Schlüsselwörter

Search

Navigation